FI955784A - Yksilön tulehdusindeksin määritys kokoveren fibrinogeeni- ja hematokriitti- tai hemoglobiinimittausten avulla - Google Patents

Yksilön tulehdusindeksin määritys kokoveren fibrinogeeni- ja hematokriitti- tai hemoglobiinimittausten avulla Download PDF

Info

Publication number
FI955784A
FI955784A FI955784A FI955784A FI955784A FI 955784 A FI955784 A FI 955784A FI 955784 A FI955784 A FI 955784A FI 955784 A FI955784 A FI 955784A FI 955784 A FI955784 A FI 955784A
Authority
FI
Finland
Prior art keywords
hematocrit
fibrinogen
determination
individual
whole blood
Prior art date
Application number
FI955784A
Other languages
English (en)
Swedish (sv)
Other versions
FI955784A0 (fi
Inventor
Brian S Bull
Robert A Levine
Stephen C Wardlaw
Original Assignee
Brian S Bull
Robert A Levine
Stephen C Wardlaw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brian S Bull, Robert A Levine, Stephen C Wardlaw filed Critical Brian S Bull
Publication of FI955784A0 publication Critical patent/FI955784A0/fi
Publication of FI955784A publication Critical patent/FI955784A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI955784A 1994-12-02 1995-12-01 Yksilön tulehdusindeksin määritys kokoveren fibrinogeeni- ja hematokriitti- tai hemoglobiinimittausten avulla FI955784A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/348,345 US5506145A (en) 1994-12-02 1994-12-02 Determination of an individual's inflammation index from whole blood fibrinogen and hematocrit or hemoglobin measurements

Publications (2)

Publication Number Publication Date
FI955784A0 FI955784A0 (fi) 1995-12-01
FI955784A true FI955784A (fi) 1996-06-03

Family

ID=23367600

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955784A FI955784A (fi) 1994-12-02 1995-12-01 Yksilön tulehdusindeksin määritys kokoveren fibrinogeeni- ja hematokriitti- tai hemoglobiinimittausten avulla

Country Status (10)

Country Link
US (1) US5506145A (fi)
EP (1) EP0715170A2 (fi)
JP (1) JPH08166389A (fi)
CN (1) CN1123914A (fi)
AU (1) AU690972B2 (fi)
CA (1) CA2149580A1 (fi)
FI (1) FI955784A (fi)
NO (1) NO954897L (fi)
RU (1) RU2122212C1 (fi)
TW (1) TW321721B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5520885A (en) * 1993-01-19 1996-05-28 Thermogenesis Corporation Fibrinogen processing apparatus, method and container
US5723285A (en) * 1996-05-30 1998-03-03 Levine; Robert A. Assembly for detecting blood-borne parasites and measuring blood sample parameters in a centrifuged sample of blood
CA2253965C (en) * 1997-11-22 2003-01-21 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US6365104B1 (en) * 1999-06-25 2002-04-02 Becton Dickinson And Company Assembly for analyzing blood samples
US6960439B2 (en) * 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US6692916B2 (en) * 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US20080183395A1 (en) * 1999-06-28 2008-07-31 Michael Bevilacqua Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
US20050060101A1 (en) * 1999-06-28 2005-03-17 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
GB0001058D0 (en) * 2000-01-17 2000-03-08 Univ Bristol Diagnostic method
WO2001097806A1 (en) * 2000-06-20 2001-12-27 Herbst Arthur L Cox-2 inhibitors and the prevention of the side effects of radiation therapy
US6514766B2 (en) * 2000-07-26 2003-02-04 Charles R. Spillert Modified erythrocyte sedimentation rate
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) * 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
KR20040064275A (ko) 2001-11-09 2004-07-16 소스 프리시전 메디슨, 인코포레이티드 유전자 발현 프로파일을 이용한 질병의 동정, 모니터링,치료 및 생물학적 상태의 확인
US20060216829A1 (en) * 2003-03-21 2006-09-28 Denis Bouboulis Erythrocyte sedimentation rate (ESR) test measurement instrument of unitary design and method of using the same
US6974701B2 (en) * 2003-03-21 2005-12-13 Hemovations, Llc Erythrocyte sedimentation rate (ESR) test measurement instrument of unitary design and method of using the same
US7892745B2 (en) * 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
SE0303249D0 (sv) * 2003-12-02 2003-12-02 Inst Polymerutveckling Ab Hematocrit and analyte concentration determination
WO2006029184A2 (en) * 2004-09-08 2006-03-16 Expression Diagnostics, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
EP1885889A4 (en) * 2005-05-11 2010-01-20 Expression Diagnostics Inc METHOD FOR MONITORING THE OPERATING STATUS OF TRANSPLANTS OVER GENLISTS
CA2648580A1 (en) * 2006-04-07 2008-05-02 Xdx, Inc. Steroid responsive nucleic acid expression and prediction of disease activity
ITUD20060177A1 (it) * 2006-07-14 2008-01-15 Sire Analytical Systems Srl Apparecchiatura integrata e metodo per la rilevazione di stati infiammatori presenti in un campione di sangue intero
WO2008021431A2 (en) * 2006-08-14 2008-02-21 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
EP2102367A2 (en) * 2006-11-09 2009-09-23 XDX, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
JP5667353B2 (ja) * 2009-09-25 2015-02-12 シスメックス株式会社 血球計数装置、診断支援装置、診断支援方法及びコンピュータプログラム
US8647886B1 (en) 2012-01-13 2014-02-11 Alcor Scientific, Inc. Apparatus, method, system for the determination of the aggregation rate of red blood cells
US9279800B2 (en) 2012-01-13 2016-03-08 Alcor Scientific, Inc. Apparatus, method, system for the determination of the aggregation rate of red blood cells
WO2015056190A1 (en) * 2013-10-16 2015-04-23 Institut National De La Sante Et De La Recherche Medicale Simultaneous monitoring of fibrinogen and haematocrit in whole blood
JP6104480B2 (ja) * 2015-03-17 2017-04-05 株式会社エム・ビー・エス 試料採取分離器具
CN106680470B (zh) * 2016-06-12 2018-12-21 北京儒展生化药物研究中心 一种测定降纤药物在人体内最大耐受剂量的方法
JP7037324B2 (ja) * 2017-01-27 2022-03-16 日本光電工業株式会社 炎症マーカー測定方法、炎症マーカー測定装置、炎症マーカー測定プログラム、および当該プログラムを記録した記録媒体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156570A (en) * 1977-04-18 1979-05-29 Robert A. Levine Apparatus and method for measuring white blood cell and platelet concentrations in blood
US4558947A (en) * 1983-11-07 1985-12-17 Wardlaw Stephen C Method and apparatus for measuring blood constituent counts
US4683579A (en) * 1985-12-27 1987-07-28 Wardlaw Stephen C Method and apparatus for measuring blood constituent counts
US4843869A (en) * 1988-03-21 1989-07-04 Levine Robert A Method for measuring hemoglobin
US4875364A (en) * 1988-03-21 1989-10-24 Levine Robert A Method for measuring hemoglobin
US4953975A (en) * 1989-01-30 1990-09-04 Levine Robert A Correction of material layer volume measurements
US5132087A (en) * 1989-10-16 1992-07-21 Kristen L Manion Apparatus for measuring blood constituent counts
US5137832A (en) * 1991-01-02 1992-08-11 Becton Dickinson & Company Quantification of fibrinogen in whole blood samples contained in a tube using a float to separate materials

Also Published As

Publication number Publication date
EP0715170A2 (en) 1996-06-05
CA2149580A1 (en) 1996-06-03
AU690972B2 (en) 1998-05-07
AU2021195A (en) 1996-06-13
NO954897L (no) 1996-06-03
US5506145A (en) 1996-04-09
RU2122212C1 (ru) 1998-11-20
JPH08166389A (ja) 1996-06-25
NO954897D0 (no) 1995-12-01
TW321721B (fi) 1997-12-01
CN1123914A (zh) 1996-06-05
FI955784A0 (fi) 1995-12-01

Similar Documents

Publication Publication Date Title
FI955784A0 (fi) Yksilön tulehdusindeksin määritys kokoveren fibrinogeeni- ja hematokriitti- tai hemoglobiinimittausten avulla
DE69530284D1 (de) Nicht-invasive nicht-spectrophotometrische infrarotmessung der konzentration von substanzen im blut
DE69032618D1 (de) Bestimmung der blutströmung
NO20000268L (no) Anvendelse av Lactobacillus for reduksjon av fibrinogen nivå i blod
DE3482625D1 (de) Probenahme und bestimmung von okkultem blut in derselben.
DE69110098D1 (de) Teststreifen zur visuellen Bestimmung der Blutglucosekonzentration.
DE69529926D1 (de) Wegwerfwindel in Höschenform
DE69422102D1 (de) Wegwerfwindel in Höschenform
DE69016348D1 (de) Leukozyten und Hämoglobin im Blut.
DE69717065D1 (de) Verwendung von thermochromen Flüssigkristallen in Diagnosemethoden mit Reflektrometrie
DE69015999D1 (de) Reagenz zur Messung von Leukozyten und Hämoglobin im Blut.
IT1205027B (it) Strumenmto di misura per bio e chemioluminescenza o per misure di estinzione
DK31088A (da) Blodkoaguleringsnedsaettende peptidderivater
DE59710933D1 (de) Messanordnung zur optischen Bestimmung der totalen Hämoglobinkonzentration
BR8901779A (pt) Absorvente higienico e metodo de aplicacao do mesmo
DE69427610D1 (de) Blutentnahmevorrichtung der Saugbarart
DE69029141D1 (de) Angioplastie mit niedrigem physiologischen stress
DE69033350D1 (de) Massnahme zur verbesserung der blutströmung
DE69635364D1 (de) Blutfilter und extrakorporaler Kreislauf
DE69019886D1 (de) Katheter und Instrumentarium zur extrakorporalen Zirkulation.
KR960702315A (ko) 혈관 차단 치료에서의 헤모글로빈의 치료적 용도 (Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage)
PT86153A (de) Optisch aktive gyrasehemmer ihre herstellung und verwendung als antibiotika
DE69333010D1 (de) Nicht-invasives verfahren und instrument zur messung des blutzuckerspiegels
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
FI955537A0 (fi) Fibrinolyyttiset ja hyytymistä estävät proteiinit

Legal Events

Date Code Title Description
FD Application lapsed